- Treatment of hepatitis B and C
- Clinical trials in viral hepatitis
- Management of antiviral-resistant hepatitis B
Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network.
CMAJ Open. 2019 Oct-Dec;7(4):E610-E617
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).
Gut. 2019 Aug 28;:
Limitations of the Avp-IRES2-Cre (JAX #023530) and Vip-IRES-Cre (JAX #010908) Models for Chronobiological Investigations.
J Biol Rhythms. 2019 Aug 27;:748730419871184
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients.
Sci Rep. 2019 Jul 19;9(1):10529
Curr Oncol. 2019 Jun;26(3):e286-e291
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trial.
BMJ Open. 2019 May 10;9(5):e024485
Combined GS-4774 and Tenofovir Therapy can Improve HBV-Specific T-Cell Responses in Patients with Chronic Hepatitis.
Gastroenterology. 2019 Mar 28;:
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B.
Liver Int. 2019 Mar 25;:
SOX2-Dependent Transcription in Clock Neurons Promotes the Robustness of the Central Circadian Pacemaker.
Cell Rep. 2019 Mar 19;26(12):3191-3202.e8
Clinician Investigator, Toronto General Hospital Research Institute (TGHRI)
Assistant Professor, Department of Medicine, University of Toronto
Site Director, Gastroenterology Education, Toronto General Hospital
GI Education Coordinator for General Internal Medicine, UHN and Mount Sinai Hospital